Determination of polysorbate 20 content in Bevacizumab injection by high performance liquid chromatography-fluorescence assay

Wei ZHAO,Sheng-rong GUO,Xin HUANG

DOI: https://doi.org/10.13200/j.cnki.cjb.002124

2018-01-01

Abstract:Objective To determine the polysorbate 20 content in Bevacizumab injection by high performance liquid chromatography (HPLC)-fluorescence assay.Methods The condition for HPLC was optimized,under which the polysorbate 20 content in Bevacizumab injection was determined.The method was verified for specificity,linearity,accuracy,precision,minimum detection limit and robustness.The polysorbate 20 contents in three batches of Bevacizumab injection were determined by the method.Results The method showed high specificity,of which the linear range was 0.20 ～ 0.60 mg / mL,with a correlation coefficient (R2) of about 0.999 9.The average recovery rates of polysorbate 20 at various concentrations were 98％ ～ 100％,with a RSD of 0.8％.The RSDs of various indexes in precision test were not more than 2％.The minimum detection limit was 0.002 0 mg/mL.The relative percentages of determination results of various indexes in robustness test under the optimized condition to those under original condition were 100％ ～ 102％.The contents in polysorbate 20 in three batches of Bevacizumab injection were 0.40,0.39 and 0.39 mg / mL,which were 100％,98％ and 98％ of the stated amounts,respectively.Conclusion The developed HPLC-fluorescence assay was rapid,accurate and reliable,which might be used for determination of the polysorbate 20 content in Bevacizumab injection.